South Africa

Trump ends SA’s HIV and TB research grants, endangering lifesaving, world class work

By Mia Malan

Maverick Citizen

‘Fund research not Tesla trucks’: The HIV casualties of Trump’s war on science

By Mia Malan

Africa

The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar

By Ida Jooste

South Africa

Some Pepfar projects reinstated: a lifeline for HIV prevention as legal battle unfolds

By Mia Malan

Maverick Citizen

COP29’s final day — developing nations demand climate financing as wealthy countries remain hesitant

By Linda Pretorius and Mia Malan

Maverick Citizen

From heatwaves to hunger: five ways climate change is compromising global health security

By Mia Malan and Linda Pretorius

Business Maverick

Medical aids in their current form are out under NHI — even if it means the end of the GNU, says Motsoaledi

By Mia Malan

Maverick Citizen

Lenacapavir — what it would it take to get the six-monthly anti-HIV jab to South Africa

By Mia Malan and Linda Pretorius

South Africa

Health department mulls new anti-HIV injection that could cut infection rates by a quarter

By Mia Malan and Linda Pretorius

South Africa

More than a million South Africans have used the HIV prevention pill

By Laura Grant and Mia Malan

South Africa

The fine line between wrong and almost right — and how that plays out during pandemics

By Nina Acharya, Helene-Mari van der Westhuizen, Mia Malan and Dave Chokshi

South Africa

More bullying? J&J will be investigated for high TB drug prices and abuse of patent laws

By Mia Malan for the Bhekisisa Centre for Health Journalism